Inhibition of ATF4 transcriptional activity by FIAT/γ-taxilin modulates bone mass accrual

Annals of the New York Academy of Sciences

Volumn 1068, Issue 1, 2006, Pages 131-142

  Yu, Vionnie W C ^a   Gauthier, Claude ^a   St Arnaud, René ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

ATF4; FIAT taxilin; Osteoblast gene transcription; Osteocalcin; NAC

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; FACTOR INHIBITING ACTIVATING TRANSCRIPTION FACTOR 4 MEDIATED TRANSCRIPTION; LEUCINE ZIPPER PROTEIN; NASCENT POLYPEPTIDE ASSOCIATED COMPLEX AND COACTIVATOR ALPHA; OSTEOCALCIN; POLYPEPTIDE; PROTEIN; UNCLASSIFIED DRUG;

BONE MASS; CELL NUCLEUS MEMBRANE; CONFERENCE PAPER; DIMERIZATION; DNA BINDING; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; OSTEOPENIA; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 33744766471     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1346.027     Document Type: Conference Paper

References (37)

1. Hai, T. & M.G. Hartman. 2001. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273: 1 11.
2. Chevray, P.M. & D. Nathans. 1992. Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proc. Natl. Acad. Sci. USA 89: 5789 5793.
3. Hai, T.W. et al. 1989. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3: 2083 2090.
4. Karpinski, B.A. et al. 1992. Molecular cloning of human CREB-2: an ATF/CREB transcription factor that can negatively regulate transcription from the cAMP response element. Proc. Natl. Acad. Sci. USA 89: 4820 4824.
5. Mielnicki, L.M. & S.C. Pruitt. 1991. Isolation and nucleotide sequence of a murine cDNA homologous to human activating transcription factor 4. Nucleic Acids Res. 19: 6332.
6. Tsujimoto, A. et al. 1991. Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I. J. Virol. 65: 1420 1426.
7. Vallejo, M. et al. 1993. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. USA 90: 4679 4683.
8. Hai, T. & T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88: 3720 3724.
9. Fawcett, T.W. et al. 1999. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem. J. 339: 135 141.
10. Lim, C. et al. 2000. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J. Gen. Virol. 81: 2645 2652.
11. Coffin, R. et al. 1966. Treatment of lead encephalopathy in children. J. Pediatr. 69: 198 206.
12. Lowry, B., J.R. Miller & F.C. Fraser. 1971. A new dominant gene mental retardation syndrome. Association with small stature, tapering fingers, characteristic facies, and possible hydrocephalus. Am. J. Dis. Child. 121: 496 500.
13. Trivier, E. et al. 1996. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384: 567 570.
14. Frodin, M. et al. 2000. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO. J. 19: 2924 2934.
15. Dalby, K.N. et al. 1998. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273: 1496 1505.
16. Fisher, T.L. & J. Blenis. 1996. Evidence for two catalytically active kinase domains in pp90rsk. Mol. Cell. Biol. 16: 1212 1219.
17. Bruning, J.C. et al. 2000. Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc. Natl. Acad. Sci. USA 97: 2462 2467.
18. Xing, J., D.D. Ginty & M.E. Greenberg. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273: 959 963.
19. Dufresne, S.D. et al. 2001. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol. Cell. Biol. 21: 81 87.
20. Yang, X. et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 117: 387 398.
21. Ducy, P. & G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15: 1858 1869.
22. Schinke, T. & G. Karsenty. 1999. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse Osteocalcin promoters. J. Biol. Chem. 274: 30182 30189.
23. Elefteriou, F. et al. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514 520.
24. Lassot, I. et al. 2001. ATF4 degradation relies on a phosphorylation- dependent interaction with the SCF(betaTrCP) ubiquitin ligase. Mol. Cell. Biol. 21: 2192 2202.
25. Yang, X. & G. Karsenty. 2004. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279: 47109 47114.
26. Xiao, G. et al. 2005. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J. Biol. Chem. 280: 30689 30696.
27. Yu, V.W. et al. 2005. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J. Cell. Biol. 169: 591 601.
28. Moreau, A. et al. 1998. Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol. Cell. Biol. 18: 1312 1321.
29. Yotov, W.V., A. Moreau & R. St-Arnaud. 1998. The alpha chain of the nascent polypeptide-associated complex functions as a transcriptional coactivator. Mol. Cell. Biol. 18: 1303 1311.
30. Nogami, S. et al. 2004. Identification and characterization of taxilin isoforms. Biochem. Biophys. Res. Commun. 319: 936 943.
31. Yoshida, K. et al. 2005. Interaction of the taxilin family with the nascent polypeptide-associated complex that is involved in the transcriptional and translational processes. Genes Cells 10: 465 476.
32. Dacquin, R. et al. 2002. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev. Dyn. 224: 245 251.
33. Rossert, J., H. Eberspaecher & B. de Crombrugghe. 1995. Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J. Cell. Biol. 129: 1421 1432.
34. Akhouayri, O., I. Quelo & R. St-Arnaud. 2005. Sequence-specific DNA binding by the {alpha}NAC coactivator is required for potentiation of c-Jun-dependent transcription of the osteocalcin gene. Mol. Cell. Biol. 25: 3452 3460.
35. Jochum, W. et al. 2000. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6: 980 984.
36. Sabatakos, G. et al. 2000. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6: 985 990.
37. Hartl, M., A.G. Bader & K. Bister. 2003. Molecular targets of the oncogenic transcription factor jun. Curr. Cancer Drug Targets 3: 41 55.